Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10647703 Inhibitors of KRAS G12C mutant proteins

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Date Filed
September 27, 2016
Date of Patent
May 12, 2020
Patent Application Number
15763798
Patent Citations
‌
US Patent 10370386 Substituted quinolines as inhibitors of KRAS G12C
‌
US Patent 10351550 Substituted quinazoline compounds and methods of use thereof
‌
US Patent 10377743 Inhibitors of RAS and methods of use thereof
‌
US Patent 10111874 Combination therapies for treatment of cancer
‌
US Patent 10144724 Substituted quinazoline compounds and methods of use thereof
Patent Citations Received
‌
US Patent 12134620 Heterocyclic spiro compounds and methods of use thereof for the treatment of cancer
0
‌
US Patent 11358959 Benzothiophene and benzothiazole compounds and methods of use thereof
‌
US Patent 11377441 Covalent inhibitors of KRAS
‌
US Patent 11878985 Substituted quinazolines as inhibitors of KRAS G12C
0
‌
US Patent 10829458 Substituted quinazoline compounds and methods of use thereof
‌
US Patent 10858343 Inhibitors of KRAS G12C mutant proteins
‌
US Patent 10919850 Covalent inhibitors of KRas G12C
‌
US Patent 10927125 Substituted cinnolines as inhibitors of KRAS G12C
‌
US Patent 10975071 Inhibitors of KRAS G12C mutant proteins
‌
US Patent 11021470 2-substituted quinazoline compounds comprising a substituted heterocyclic group and methods of use thereof
•••
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10647703
Patent Primary Examiner
‌
Laura L. Stockton

Find more entities like US Patent 10647703 Inhibitors of KRAS G12C mutant proteins

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.